These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506 [TBL] [Abstract][Full Text] [Related]
30. Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management. Gertz MA Am J Hematol; 2015 Apr; 90(4):346-54. PubMed ID: 25808108 [TBL] [Abstract][Full Text] [Related]
31. Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions. Anagnostopoulos A; Aleman A; Giralt S Semin Oncol; 2003 Apr; 30(2):286-90. PubMed ID: 12720154 [TBL] [Abstract][Full Text] [Related]
34. [Therapy of Waldenström´s macroglobulinaemia in the year 2014]. Adam Z; Krejčí M; Pour L; Ševčíková E Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia. Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L Bone Marrow Transplant; 1999 Apr; 23(7):747-9. PubMed ID: 10218857 [TBL] [Abstract][Full Text] [Related]
36. Novel agents in the treatment of Waldenström's macroglobulinemia. Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845 [TBL] [Abstract][Full Text] [Related]